Ambulatory Trial Unit

Clinical conduct in an outpatient setting

In the realm of vaccine trials, spanning from phase I through phase IV, volunteers engage in multiple visits to the unit for various clinical trial assessments before returning home. This process involves a meticulous evaluation of the vaccines under investigation.

Key Points:

Focusses on Phase I to IV vaccine trials

Volunteers attend multiple clinical trial visits

Following each visit, volunteers return home for the day

The unit can accommodate at least 32 subject visits daily, facilitating efficient trial procedures

Want to know more?

Want to be a volunteer?

Expertise

Over 500 vaccine trials have been conducted across diverse age groups, encompassing both healthy volunteers and patient populations and this in various pathogens:

Clinical Trial Phases

Viral infections

Respiratory: Influenza,Respiratory Syncytial Virus (RSV), SARS-CoV-2

Gastrointestinal: Norovirus, Rotavirus, Hepatitis

Others: Polio, Ross River, Lassa, Ebola, Humane Papilloma Virus (HPV), Herpes, Cytomegalovirus (CMV)

Bacterial infections

Respiratory: Streptococcus,Diphtheria

Gastrointestinal: Salmonella, Escherichia coli

Others: Meningococcus

Combination Vaccine: Diphtheria-Tetanus-Pertussis

Facility

The Ambulatory Trial Unit has a capacity of at least 32 ambulatory subject visits per day and consists of:

Reception zone with 2 waiting areas

4 consultation rooms

3 rooms for sample collection and vaccination